Prenatal Paternity Test During Pregnancy

A prenatal paternity test can establish a biological link between an alleged father and a baby before birth. For some couples, this step provides clarity and peace of mind before the child arrives.

During pregnancy, there are two main approaches: the non-invasive prenatal paternity test and the invasive prenatal test. These methods do not rely on the same type of sample, do not offer the same level of comfort, and do not involve the same constraints.

What types of paternity tests are available during pregnancy?

There are two main categories of tests:

• the non-invasive prenatal test;

• the invasive prenatal test.

The key difference lies in how the sample is collected and in the level of risk associated with the procedure.

The non-invasive prenatal test

The non-invasive prenatal paternity test is based on a simple process: a blood sample from the mother and a cheek swab from the alleged father. The laboratory then compares the foetal DNA circulating in the mother’s blood with the alleged father’s genetic profile in order to assess biological parentage.

This technique is painless and does not involve any direct risk to the mother or the baby. Reported results are generally highly accurate, often around 99%. The principle behind this analysis is the use of cell-free foetal DNA circulating in maternal blood, which can be analysed during pregnancy without an invasive procedure. If you want to understand the practical side of sampling, you can read how to take a blood sample for a prenatal DNA test.

In practice, the analysis is generally possible from the 7th week of pregnancy onwards and can then be carried out at any stage after that. As the pregnancy progresses, the amount of detectable foetal DNA usually becomes easier for the laboratory to work with.

This is consistent with how InfotestADN presents its prenatal DNA testing services, including its broader prenatal DNA tests.

The limits of the non-invasive test

Although this method is reliable, it is not completely infallible. The accuracy of the result depends in particular on how much DNA from the baby the laboratory is able to extract from the mother’s blood sample.

In some cases, the maternal sample does not contain enough foetal genetic material to allow a reliable comparison with the alleged father’s DNA. When that happens, laboratories generally suggest taking a new sample, often around two weeks later.

This may happen in pregnancies with certain specific features or in the presence of particular medical factors. However, an insufficient amount of usable foetal DNA does not automatically mean there is a problem with the pregnancy. Pregnancy follow-up still relies above all on clinical assessment, blood tests and ultrasound scans, which are used to monitor maternal wellbeing and foetal development.

The invasive prenatal test

Invasive prenatal tests involve more complex medical procedures, such as:

• amniocentesis;

• CVS (chorionic villus sampling);

• trophoblast biopsy.

These techniques involve collecting cells or tissue from the amniotic fluid, the placenta or, depending on the situation, other pregnancy-related structures.

Why are these methods considered invasive?

They are described as invasive because they require an internal medical sampling procedure. They are therefore not comparable to a simple blood draw.

These procedures carry a risk of miscarriage, even though that risk remains low. In England, NHS guidance states that the miscarriage risk is estimated at up to 1 in 200 after amniocentesis, while the chance after CVS is thought to be less than 1 in 200 for most pregnancies and slightly higher in multiple pregnancies.

Why are the results more precise?

Invasive tests provide more biological material for analysis. The laboratory therefore has a larger amount of genetic material available to check whether the alleged father’s DNA matches the baby’s.

These examinations may also provide other information, including the baby’s sex or certain genetic predispositions.

In which situations are invasive tests considered?

Invasive prenatal tests are generally considered when there is a higher risk of a genetic abnormality in the baby. For example, they may help diagnose certain chromosomal conditions such as Down’s syndrome.

In practice, the decision to use this type of test depends on the parents’ medical history, maternal age, and the results of blood tests and ultrasound scans. In England, NHS guidance explains that CVS and amniocentesis are diagnostic tests offered when there is an increased chance of a genetic or chromosomal condition.

If an invasive test is being considered, it is important to discuss the advantages, limitations and risks of each option with a doctor before making a decision.

Is it better to take the test during pregnancy or wait until birth?

In some situations, it may be simpler and less expensive to wait until after birth to carry out a paternity test. Once the baby is born, DNA comparison based on saliva samples is more straightforward.

Waiting until birth may also offer an additional advantage: it becomes possible to carry out a test with legal value, which may be useful in a judicial or administrative context. By contrast, a prenatal test does not necessarily serve the same purpose. This distinction is in line with the way InfotestADN presents its paternity test options and their different uses.

Conclusion

A prenatal paternity test can provide an answer before birth, but not all methods are equal. The non-invasive prenatal paternity test is appealing because of its simplicity and the absence of direct risk to the pregnancy, while invasive methods provide more biological material at the cost of a more complex medical procedure.

The right choice therefore depends on your situation, your expectations and the medical context. When uncertainty arises during pregnancy, it is essential to distinguish between a personal need for information, a medical concern and the possibility of needing a result for future legal use. To explore related prenatal testing options, you can also look at the baby gender test.